Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: GINKGO BIOWORKS HOLDINGS INC C/WTS 16/09/2026 (TO PUR COM)(DNABW) the Revenue is 20.16 M (-59.37%), Miss estimate;the EBIT is -58.55 M (+10.67%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.02B59.37%
0.02B49.90%
-0.00B9.47%
EBITMiss expectations
-0.06B10.67%
-0.05B18.07%
-0.00B7.40%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf